Symbols / ADAP
ADAP Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-10 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- ADAPTIMMUNE THERAPEUTICS Earnings Preview: Recent $ADAP Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative Fri, 05 Dec 2025 08
- Oct 27 trading suspension — Adaptimmune to voluntarily delist ADSs from Nasdaq; Form 25 filing Oct 28, 2025 - Stock Titan Mon, 20 Oct 2025 07
- How Liminatus Pharma Inc. stock responds to policy changes - Quarterly Earnings Report & Expert Curated Trade Setup Alerts - Naître et grandir Sat, 07 Mar 2026 18
- Adaptimmune stock plunges after announcing Nasdaq delisting plans - Investing.com Mon, 20 Oct 2025 07
- Why Is Adaptimmune Therapeutics Stock (ADAP) Rising Today? - TipRanks hu, 09 Oct 2025 07
- Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real? - TechStock² Wed, 08 Oct 2025 07
- ADAPTIMMUNE THERAPEUTICS Earnings Results: $ADAP Reports Quarterly Earnings - Nasdaq ue, 13 May 2025 07
- Adaptimmune Therapeutics PLC (ADAP) Q1 2025 Earnings Call Highlights: Strong Tecelra Launch ... - Yahoo Finance Wed, 14 May 2025 07
- $ADAP stock is down 16% today. Here's what we see in our data. | ADAP Stock News - Quiver Quantitative ue, 14 Oct 2025 07
- Ecor1 capital sells Adaptimmune Therapeutics (ADAP) shares for $6.89m - Investing.com Wed, 30 Jul 2025 07
- Adaptimmune's Groundbreaking Cell Therapy Assets Acquired by US WorldMeds in $85M Strategic Deal - Stock Titan Mon, 28 Jul 2025 07
- Adaptimmune Therapeutics to Delist from Nasdaq by October 27 - TipRanks Mon, 20 Oct 2025 07
- Adaptimmune Therapeutics Stock (ADAP) Opinions on Recent Corporate Transactions - Quiver Quantitative Wed, 20 Aug 2025 07
- Adaptimmune Stock’s Wild 2025 Ride: Speculative Surge or True Biotech Comeback? - TechStock² hu, 09 Oct 2025 07
- Adaptimmune Reports Q1 Financial Results and Provides Business Update - Stock Titan ue, 13 May 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for ADAP
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|